Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0PKSGZ)
| ADC Name |
US20220226492A1 Immunoconjugate K1
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
Immunoconjugate K1
Click to Show/Hide
|
|||||
| Organization |
BOLT BIOTHERAPEUTICS, INC. | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.73
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||